Physician profile

Sripal Bangalore

Interventional Cardiology · New York, NY

NPI 1902066871

$481,580.43

in general payments reported to CMS, 2019-2025

26 companies · $127K in 2025

The $127K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$218,381.86
Travel and Lodging$75,697.48
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$65,376.00
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program$12,650.00
Food and Beverage$12,249.38
Honoraria$2,000.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Mylan INC. $194,901.30 2022-2025 Norvasc
Abbott Laboratories $59,976.24 2019-2025 Dragonfly Opstar, Optis, Pressurewire
Inari Medical, INC. $38,926.43 2021-2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Imperative Care, INC $29,508.03 2023-2025 Zoom 88-T Large Distal Platform, Symphony Catheter
Angiodynamics, INC. $28,774.55 2019-2025 Alphavac, Angiovac, Auryon Laser System 100-120 Vac
Boston Scientific Corporation $20,321.74 2021-2025 General - Structural Heart, Avvigo Guidance System, Rotapro
Stryker Corporation $17,911.64 2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever
Amgen INC. $16,403.44 2019-2021
Shockwave Medical, INC $13,821.15 2021-2024 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Truvic Medical, INC. $13,107.47 2022
Biotronik INC. $12,318.53 2019-2023
Boehringer Ingelheim Mena (Scientific Office) Fz-LLC $12,265.80 2021
Recor Medical INC $10,568.25 2025 Paradise Ultrasound Renal Denervation System
Pfizer INC. $3,500.00 2019
Merck Sharp & Dohme LLC $3,355.00 2022
Show all 25 companies
CompanyGeneral paymentsYearsTop products
Magenta Medical INC $2,250.00 2023-2024
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $2,000.00 2025 Lifevest
Argon Medical Devices, INC. $645.47 2022-2024 Cleaner, Clot Management
Terumo Medical Corporation $350.00 2022
Medtronic, INC. $240.64 2022-2023 Onyx Frontier, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan
Zoll Circulation INC $239.00 2024 Catheter, Therox Ds2 Console, Downstream Cartridge
Abiomed $64.24 2025
Cardiva Medical, INC. $63.13 2025 Cardiva Vascade Mvp Vvcs 6-12f
W. L. Gore & Associates, INC. $34.40 2025 Gore Cardioform Septal Occluder
Siemens Medical Solutions USA, INC. $33.98 2022

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sripal Bangalore

$481,580.43

in general payments reported 2019-2025

Years
2019-2025
Top company
Mylan INC.
Context
The $127K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/131013/sripal-bangalore

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.